---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042455"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T10:00:15.160968+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Daré Bioscience makes corporate presentation available to investors

## Summary
- Company filed a corporate presentation dated October 25, 2024 as Exhibit 99.1.
- Presentation will be used in meetings with investors and analysts starting October 25, 2024.
- Copy available on company's investor relations website under Presentations section.
- No specific financial or pipeline updates disclosed in the filing; presentation content not provided.
- Filing is routine Regulation FD disclosure; no material new information can be confirmed.

## SEC filing metadata
- accession: 0001493152-24-042455
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315224042455/0001493152-24-042455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315224042455/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042455
- JSON: https://secwatch.observer/filing/0001493152-24-042455.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042455.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.